首页> 外文期刊>ACS applied materials & interfaces >Reduction-Responsive Core-Shell-Corona Micelles Based on Triblock Copolymers: Novel Synthetic Strategy, Characterization, and Application As a Tumor Microenvironment-Responsive Drug Delivery System
【24h】

Reduction-Responsive Core-Shell-Corona Micelles Based on Triblock Copolymers: Novel Synthetic Strategy, Characterization, and Application As a Tumor Microenvironment-Responsive Drug Delivery System

机译:基于三嵌段共聚物的还原响应型核-壳-电晕胶束:新型合成策略,表征和作为肿瘤微环境响应药物传递系统的应用。

获取原文
获取原文并翻译 | 示例
           

摘要

A facile and effective approach was established for fabricating core-shell-corona micelles by self-assembly of poly(ethylene glycol)-b-poly(acrylic acid-co-tert-butyl acrylate)-poly(epsilon-caprolactone) (PEG(43)-b-P(AA(30)-co-tBA(18))-b-PCL53) triblock copolymer, synthesized via a combination of ring-opening polymerization (ROP), atom transfer radical polymerization (ATRP), click chemistry, and hydrolyzation. The prenanovehicles with three different hydrolysis degrees from PEG(43)-b-PtBA(48)-b-PCL53 were developed to evaluate the drug loading capacity (DLC) and drug encapsulation efficiency (DEE). After cross-linking with a disulfide bond to regulate the drug release kinetics, the spherical core-shell-corona micelles with average diameter of 52 +/- 4 nm were obtained in aqueous solution. The reduction-responsive cross-linked micelles showed a slow sustained release in normal physiological conditions and a rapid release upon exposure to simulated tumor intracellular conditions. In addition, the cytotoxic analysis and HepG2 cell growth inhibition assays demonstrated their remarkable biocompatibility and similar excellent anticancer activity as the free doxorubicin (DOX), which has also been revealed by the confocal laser scanning microscope (CLSM) analysis. So the reduction-sensitive core-shell-corona micelles are expected to be promising tumor microenvironment-responsive nanovehicles for hydrophobic drugs by glutathione (GSH) triggering.
机译:通过自组装聚(乙二醇)-b-聚(丙烯酸-丙烯酸丙烯酸叔丁酯)-聚(ε-己内酯)(PEG()的方法,建立了一种简便有效的方法来制备核-壳-电晕胶束43)-bP(AA(30)-co-tBA(18)-b-PCL53)三嵌段共聚物,通过开环聚合(ROP),原子转移自由基聚合(ATRP),点击化学和水解。从PEG(43)-b-PtBA(48)-b-PCL53具有三种不同水解度的前鼻病毒被开发来评估载药量(DLC)和包囊效率(DEE)。用二硫键交联以调节药物释放动力学后,在水溶液中获得平均直径为52 +/- 4 nm的球形核-壳-电晕胶束。还原反应性交联的胶束在正常生理条件下显示出缓慢的持续释放,而在暴露于模拟肿瘤细胞内条件下则显示出快速释放。此外,细胞毒性分析和HepG2细胞生长抑制试验证明它们具有显着的生物相容性,并且具有与游离阿霉素(DOX)类似的优异抗癌活性,这也已通过共聚焦激光扫描显微镜(CLSM)分析得以揭示。因此,通过谷胱甘肽(GSH)触发,对还原敏感的核-壳-电晕胶束有望成为有前景的针对疏水药物的肿瘤微环境响应纳米载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号